Cannabis Seed And Immature Cannabis Plant Labeling

A. Unless otherwise provided, cannabis seeds and immature cannabis plants sold to consumers, qualified patients, or reciprocal patients shall meet the minimum labeling requirements of this section. B. The label shall be printed on or affixed to the container or receptacle and printed on or affixed to any outer package or container that is used to display the cannabis seed or immature cannabis plant for retail sale. C. Font size used on a label shall be no smaller than 1/16 of an inch by measuring the height of a lower-case letter “o”. D. The label shall be in English, though it can be in other languages. E. The label shall be unobstructed and conspicuous. F. The label shall not contain any untruthful or misleading statements including, but not limited to, health or benefit claims. G. The principal display panel shall include: (1) the product identity or common name in bold type, in a size reasonably related to the most prominent printed matter on the principal display panel; (2) potential potency, as confirmed by a cannabis testing laboratory of the parent cannabis plant; and (3) a logo designed and provided by the division that is no smaller than 1/2 inch by 1/2 inch. H. For cannabis seeds the display panel shall also include net quantity of seeds. I. Cannabis seed and immature cannabis plant labels shall have an information panel or static quick response (QR) code that links to or contains the following without intervening material: (1) if applicable, the cannabis manufacturer business or trade name; (2) if applicable, unless the business or trade name placed on the package is the actual manufacturer, a qualifying phrase which states the firm's relation to the product (e.g., “manufactured for” or “distributed by”); (3) if applicable, cannabis manufacturer license number; (4) pesticide used in the product by the cannabis producer; (5) if applicable, date product was manufactured; (6) the following warning statement in bold font “For use only by adults 21 and older. Keep out of reach of children.” [16.8.3.10 NMAC - N, 04/01/2022] 16.8.3.11 CANNABIS FINISHED PRODUCT LABELING IN CANNABIS CONSUMPTION AREAS: Packaging and labeling exemptions and minimum requirements. A licensed cannabis consumption area may sell cannabis products to a consumer, qualified patient, or reciprocal patient without packaging and labeling under the following conditions: A. the consumer, qualified patient, or reciprocal patient intends to consume cannabis product on the licensed premises of the cannabis consumption area and will store unused product on the premises as required by cannabis consumption area licensing requirements in 16.8.2 NMAC; B. at the time of transfer of the cannabis finished product to a consumer, the licensed cannabis consumption area provides the consumer with a written statement of the potency of the cannabis product’s THC or Total THC, and CBD, which shall be expressed as a percentage for inhaled cannabis finished products, and expressed in milligrams for edible cannabis finished products and topical cannabis finished products. If CBD is not detected in the inhaled cannabis finished product, then CBD potency is not required; C. the licensed cannabis consumption area maintains and makes available to the consumer, qualified patient, or reciprocal patient upon request written or electronic documentation reflecting all relevant information required in cannabis consumption area licensing requirements 16.8.2 NMAC; and D. for multiple-serving edible cannabis finished product, the licensed cannabis consumption area at the time of transfer to the consumer, qualified patient, or reciprocal patient shall provide a measurement device necessary for the purchaser to achieve accurate measurements of each serving in increments equal to or less than 10 milligrams of Total THC per serving.